Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial

Soraiya Ebrahimpour-Koujan,Amir Ali Sohrabpour,Edward Giovannucci,Akram Vatannejad,Ahmad Esmaillzadeh
DOI: https://doi.org/10.1186/s12937-024-00911-x
2024-02-29
Nutrition Journal
Abstract:Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global metabolic problem which can lead to irreversible liver fibrosis. It has been shown that vitamin D and its receptors contribute to fibrogenic pathways in the liver. However, the effect of vitamin D supplementation on liver fibrosis related factors have not been examined. This double blinded placebo controlled clinical trial was designed to investigate the effects on vitamin D supplementation on serum levels of VDR, fibrogenic factors and fibrogenic MicroRNAs in MASLD patients.
nutrition & dietetics
What problem does this paper attempt to address?